The Geoepidemiology and Clinical Aspects of IgG4-Related Disease

Kazushige Uchida, Toshihiro Tanaka, M. Eric Gershwin, Kazuichi Okazaki

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Immunoglobulin G4-related disease (IgG4-RD) is a recently described systemic inflammatory disease characterized by increased serum IgG4 concentrations, lymphoplasmacytic infiltrations, storiform fibrosis, and obliterative phlebitis. However, although IgG4-RD has become increasingly recognized, the number of patients with IgG4-RD remains unclear. Data from several studies indicate that patients who have a T-helper type 2 (Th2-) dominant immune response, which leads to the hyperproduction of Th2 cytokines, then progress to IgG4-RD. Glucocorticoids are the most common treatment for IgG4-RD and generally, patients have a good response-a characteristic of IgG4-RD. However, relapses during the tapering of glucocorticoid therapy are common. Second-line therapy after glucocorticoids includes immunosuppressant agents. Although the long-term outcome still remains unclear, there is increased interest in the relationships between IgG-RD and malignancies. In this review, the authors provide a detailed overview of the geoepidemiology, pathogenesis, diagnostic features, treatment, and prognosis of IgG4-RD.

Original languageEnglish (US)
Pages (from-to)187-199
Number of pages13
JournalSeminars in Liver Disease
Volume36
Issue number3
DOIs
StatePublished - Aug 1 2016

Fingerprint

Immunoglobulin G
Immunoglobulins
Glucocorticoids
Phlebitis
Therapeutics
Immunosuppressive Agents
Fibrosis
Cytokines
Recurrence
Serum
Neoplasms

Keywords

  • cytokines
  • geoepidemiology
  • immunoglobulin G4
  • immunoglobulin G4-related disease
  • T-helper type 2

ASJC Scopus subject areas

  • Hepatology

Cite this

The Geoepidemiology and Clinical Aspects of IgG4-Related Disease. / Uchida, Kazushige; Tanaka, Toshihiro; Gershwin, M. Eric; Okazaki, Kazuichi.

In: Seminars in Liver Disease, Vol. 36, No. 3, 01.08.2016, p. 187-199.

Research output: Contribution to journalArticle

Uchida, Kazushige ; Tanaka, Toshihiro ; Gershwin, M. Eric ; Okazaki, Kazuichi. / The Geoepidemiology and Clinical Aspects of IgG4-Related Disease. In: Seminars in Liver Disease. 2016 ; Vol. 36, No. 3. pp. 187-199.
@article{25ba2155ea1342049c7a6cccae6ef454,
title = "The Geoepidemiology and Clinical Aspects of IgG4-Related Disease",
abstract = "Immunoglobulin G4-related disease (IgG4-RD) is a recently described systemic inflammatory disease characterized by increased serum IgG4 concentrations, lymphoplasmacytic infiltrations, storiform fibrosis, and obliterative phlebitis. However, although IgG4-RD has become increasingly recognized, the number of patients with IgG4-RD remains unclear. Data from several studies indicate that patients who have a T-helper type 2 (Th2-) dominant immune response, which leads to the hyperproduction of Th2 cytokines, then progress to IgG4-RD. Glucocorticoids are the most common treatment for IgG4-RD and generally, patients have a good response-a characteristic of IgG4-RD. However, relapses during the tapering of glucocorticoid therapy are common. Second-line therapy after glucocorticoids includes immunosuppressant agents. Although the long-term outcome still remains unclear, there is increased interest in the relationships between IgG-RD and malignancies. In this review, the authors provide a detailed overview of the geoepidemiology, pathogenesis, diagnostic features, treatment, and prognosis of IgG4-RD.",
keywords = "cytokines, geoepidemiology, immunoglobulin G4, immunoglobulin G4-related disease, T-helper type 2",
author = "Kazushige Uchida and Toshihiro Tanaka and Gershwin, {M. Eric} and Kazuichi Okazaki",
year = "2016",
month = "8",
day = "1",
doi = "10.1055/s-0036-1584323",
language = "English (US)",
volume = "36",
pages = "187--199",
journal = "Seminars in Liver Disease",
issn = "0272-8087",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - The Geoepidemiology and Clinical Aspects of IgG4-Related Disease

AU - Uchida, Kazushige

AU - Tanaka, Toshihiro

AU - Gershwin, M. Eric

AU - Okazaki, Kazuichi

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Immunoglobulin G4-related disease (IgG4-RD) is a recently described systemic inflammatory disease characterized by increased serum IgG4 concentrations, lymphoplasmacytic infiltrations, storiform fibrosis, and obliterative phlebitis. However, although IgG4-RD has become increasingly recognized, the number of patients with IgG4-RD remains unclear. Data from several studies indicate that patients who have a T-helper type 2 (Th2-) dominant immune response, which leads to the hyperproduction of Th2 cytokines, then progress to IgG4-RD. Glucocorticoids are the most common treatment for IgG4-RD and generally, patients have a good response-a characteristic of IgG4-RD. However, relapses during the tapering of glucocorticoid therapy are common. Second-line therapy after glucocorticoids includes immunosuppressant agents. Although the long-term outcome still remains unclear, there is increased interest in the relationships between IgG-RD and malignancies. In this review, the authors provide a detailed overview of the geoepidemiology, pathogenesis, diagnostic features, treatment, and prognosis of IgG4-RD.

AB - Immunoglobulin G4-related disease (IgG4-RD) is a recently described systemic inflammatory disease characterized by increased serum IgG4 concentrations, lymphoplasmacytic infiltrations, storiform fibrosis, and obliterative phlebitis. However, although IgG4-RD has become increasingly recognized, the number of patients with IgG4-RD remains unclear. Data from several studies indicate that patients who have a T-helper type 2 (Th2-) dominant immune response, which leads to the hyperproduction of Th2 cytokines, then progress to IgG4-RD. Glucocorticoids are the most common treatment for IgG4-RD and generally, patients have a good response-a characteristic of IgG4-RD. However, relapses during the tapering of glucocorticoid therapy are common. Second-line therapy after glucocorticoids includes immunosuppressant agents. Although the long-term outcome still remains unclear, there is increased interest in the relationships between IgG-RD and malignancies. In this review, the authors provide a detailed overview of the geoepidemiology, pathogenesis, diagnostic features, treatment, and prognosis of IgG4-RD.

KW - cytokines

KW - geoepidemiology

KW - immunoglobulin G4

KW - immunoglobulin G4-related disease

KW - T-helper type 2

UR - http://www.scopus.com/inward/record.url?scp=84982745260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982745260&partnerID=8YFLogxK

U2 - 10.1055/s-0036-1584323

DO - 10.1055/s-0036-1584323

M3 - Article

C2 - 27466790

AN - SCOPUS:84982745260

VL - 36

SP - 187

EP - 199

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

SN - 0272-8087

IS - 3

ER -